Short interest in CytoMed Therapeutics Ltd (NASDAQ:GDTC) increased during the last reporting period, rising from 38.81K to 39.25K. This put 2.3% of the company's publicly available shares short.

Short interest for CytoMed Therapeutics gives investors a sense of the degree to which investors are betting on the decline of CytoMed Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 2.21K shares traded per day, it would take 17.79 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.